TEMPLE, Texas – A new comparative study, recently conducted by Advance Pharmaceutical Inc. in association with Orion Institute for Translational Medicine and Praava Health, reveals the potential benefits of a ground-breaking dietary supplement, Revivify, in restoring skin well-being among those suffering from Acne Vulgaris.
Acne Vulgaris, a common chronic inflammatory skin condition affecting a significant proportion of the global population, particularly adolescents, poses challenges to dermatologists due to its complex pathogenesis. The condition primarily results from the overproduction of sebum by the sebaceous gland, leading to the clogging of hair follicles and bacterial accumulation, among other complications.
Addressing these concerns, Advance Pharmaceutical Inc. introduced Revivify, a dietary supplement designed to enhance the body's inherent antioxidant defense system. Enriched with superoxide dismutase, prebiotic fiber, and diverse polyphenols from fruit juice, Revivify stimulates the immune system, promotes anti-inflammatory reactions, and works at the cellular level to repair damage caused by free radicals.
The study's objective was to evaluate the impact of Revivify on the Bangladeshi population suffering from Acne Vulgaris.
The researchers conducted a case-control study in different clinics under Dhaka North City Corporation, Bangladesh, involving 20 patients suffering from moderate to severe ranges of Acne Vulgaris, uneven skin tone, post-inflammatory hyperpigmentation, and scars.
The results were promising. The researchers found that patients using Revivify, along with Oral Doxycycline and tropical therapy, saw a significant reduction in blemishes, inflammation levels, and post-inflammatory effects, such as hyperpigmentation and scars, compared to the control group.
Revivify shows potential in restoring skin well-being among the Bangladeshi population. However, we still see the need for large-scale studies to measure the significant impact of this medication and help dermatologists avoid the overuse of antibiotics.
Advance Pharmaceutical Inc. has patented Revivify, underscoring its confidence in the product's potential as a game-changer in the skincare industry. As the scientific community continues to explore Revivify's full potential, it could soon become a reliable supplement to boost skin health for those dealing with chronic skin conditions.
About Advance Pharmaceutical Inc:
Advance Pharmaceutical Inc., based in Holtsville, NY, is a leading pharmaceutical company committed to developing innovative health solutions. The company's groundbreaking product, Revivify, is a testament to its dedication to improving the quality of life for individuals suffering from skin conditions.
REVIVIFY® is a high-quality, patented, and advanced health supplement manufactured with primary antioxidants delivered at a cellular level. Our company is based out of New York and can ship our products anywhere in the world. Our products are patented (U.S. Patent: 11, 224, 636). Check out more science behind our product and how it works on a cellular level.
For media inquiries, please contact:
Advance Pharmaceutical Inc.